ذكاء اصطناعي يقود ثورة في علاج التصلب الجانبي
Google DeepMind and partners from Boston Children’s Hospital and MIT are collaborating to develop RNA-based therapies for amyotrophic lateral sclerosis (ALS). This initiative integrates AI-driven biological modeling with experimental lab work to accelerate therapeutic discovery. The approach represents a convergence of computational biology and clinical neuroscience.